Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Localized Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06631521
What this trial is testing

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate CAProstate Cancer (Adenocarcinoma)Prostate Cancer Surgery
AdventHealth 30
Testing effectiveness (Phase 2)UnknownNCT03845751
What this trial is testing

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.

Who this might be right for
Prostate CancerAndrogen Deprivation Therapy
Institut Mutualiste Montsouris 20
Not applicableStudy completedNCT02662673
What this trial is testing

Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device

Who this might be right for
Localized Prostate Cancer
Hospices Civils de Lyon 39
Testing effectiveness (Phase 2)Looking for participantsNCT07550517
What this trial is testing

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Who this might be right for
High-Risk Localized Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Looking for participantsNCT05593497
What this trial is testing

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Who this might be right for
High-Risk Prostate Cancer
VA Office of Research and Development 30
Testing effectiveness (Phase 2)Looking for participantsNCT05726292
What this trial is testing

Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Chicago 90
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Not applicableActive Not RecruitingNCT04909294
What this trial is testing

Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Prostate
Centre Georges Francois Leclerc 68
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430192
What this trial is testing

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Who this might be right for
Prostatic Neoplasms
Peter MacCallum Cancer Centre, Australia 20
Not applicableLooking for participantsNCT07792993
What this trial is testing

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Who this might be right for
Localized Prostate Cancer
Regina Elena Cancer Institute 82
Not applicableStudy completedNCT04602208
What this trial is testing

FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMES

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 146
Testing effectiveness (Phase 2)Study completedNCT00005096
What this trial is testing

Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 19
Post-approval studies (Phase 4)Not Yet RecruitingNCT07766122
What this trial is testing

Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU

Who this might be right for
Prostate Cancer - RecurrentProstate Cancer (Diagnosis)
University Hospital, Toulouse 30
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Testing effectiveness (Phase 2)UnknownNCT00987675
What this trial is testing

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 26
Not applicableLooking for participantsNCT07757490
What this trial is testing

Sonablate HIFU International Registry for PC & BPH Patients

Who this might be right for
Localized Prostate CancerBPH (Benign Prostatic Hyperplasia)Prostate Cancer; Benign Prostatic Hyperplasia
Sonablate 10,000
Large-scale testing (Phase 3)Study completedNCT00033631
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,534
Not applicableWithdrawnNCT07541066
What this trial is testing

Robotic Telesurgery in Urology

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04136353
What this trial is testing

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Who this might be right for
Prostate Cancer
University of Sydney 1,100
Next Page